AdipoLABs successfully cooperates in medical tourism with Sichuan Province, China
24-07-30 11:15 283회 0건
AdipoLABs
successfully cooperates in medical tourism with Sichuan Province, China
Accelerate project progress by providing an
in-depth exchange platform and promote the prosperity of the medical tourism
industry in both countries
[Medical
Newspaper/Daily Newspaper = Reporter Oh In-gyu] AdipoLABs (CEO Sung-ho Han), a
domestic cancer treatment device manufacturer, announced on the 26th that it
had recently successfully carried out medical tourism cooperation with Sichuan
Province, China, for a 4-day, 3-night schedule.
(Center of photo)
CEO Han Sung-ho is signing an agreement to promote the development of the
Korea-China medical tourism business.
The itinerary
of CEO Han Sung-ho's personal visit consisted of a visit to the Elderly
Association of Chengdu, Sichuan Province, a visit to Sichuan Yui Hospital, an
exchange with the Chengdu Cancer Association, and a Korea-China medical tourism
seminar.
The
Korea-China medical tourism seminar, which became a particular highlight, is a
cooperation platform for companies to promote Korea-China medical tourism
cooperation as companies are actively seeking cooperation opportunities to
promote the development of the medical tourism industry in both countries as
interest in Korea-China medical tourism cooperation has recently increased. The
goal is to promote the prosperity of the medical tourism industry in both
countries by providing and accelerating the progress of the project. The visit
has received great attention.
Based on this,
parties will promote in-depth exchanges and project cooperation between Korean
and Chinese medical tourism companies and jointly discover new areas of
business cooperation.
Through the
introduction of corporate projects, attendees were able to gain a more
comprehensive understanding of the latest development trends, project
characteristics, and advantages of the Korean-Chinese medical tourism industry.
CEO Han Sung-ho
said, “We will strengthen cooperation and partnerships between Korean and
Chinese medical tourism-related companies and promote joint development through
processes such as negotiation, exchange, and MOU signing.”
Meanwhile, AdipoLABs is a specialized manufacturer of hyperthermia
cancer treatment devices and obesity equipment using high frequency. It
develops, manufactures, and sells medical, personal, and home medical devices
based on high frequency core technology and creative ideas thanks to its pure
domestic technology.
The
representative device, REMISSION 1℃, is a medical device that can relieve pain through deep heat by raising
body temperature above 40℃. Hyperthermia
is widely used in cancer treatment due to its effectiveness in improving blood
circulation and immunity. Distribution began in Korea in 2019. About 80 medical
institutions, including Seoul St. Mary's Hospital of the Catholic University of
Korea, are using REMISSION 1℃. The company
received permission from the Ministry of Food and Drug Safety in 2015, and FDA
and Halal certification in 2018.
Source:
AdipoLABs successfully cooperates in medical tourism with Sichuan Province,
China < Medical devices/IT < Text of article - Medical Newspaper
(bosa.co.kr)